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Abstract
A small-plaque variant (SP) of West Nile virus (WNV) was isolated in Vero cell culture from kidney tissue of an American crow collected in
New York in 2000. The in vitro growth of the SP and parental (WT) strains was characterized in mammalian (Vero), avian (DF-1 and PDE), and
mosquito (C6/36) cells. The SP variant replicated less efficiently than did the WT in Vero cells. In avian cells, SP growth was severely restricted at
high temperatures, suggesting that the variant is temperature sensitive. In mosquito cells, growth of SP and WT was similar, but in vivo in Culex
pipiens (L.) there were substantial differences. Relative to WT, SP exhibited reduced replication following intrathoracic inoculation and lower
infection, dissemination, and transmission rates following oral infection. Analysis of the full length sequence of the SP variant identified sequence
differences which led to only two amino acid substitutions relative to WT, prM P54S and NS2A V61A.
© 2007 Elsevier Inc. All rights reserved.Keywords: West Nile virus; Small plaque variant; Wild-type; Temperature sensitivity; Culex pipiens; Vector competenceIntroduction
West Nile virus (WNV) is an arthropod-borne virus
belonging to the family Flaviviridae, genus Flavivirus that
exists primarily in a mosquito–avian transmission cycle. WNV,
which had been geographically limited to Africa, the Middle
East, India, Australasia, and western and central Asia, was first
introduced into the northeastern United States in 1999
(Lanciotti et al., 1999) and has since spread throughout the
United States, into Canada, Mexico, the Caribbean, Latin
America, and South America (Austin et al., 2004; Blitvich et al.,
2003; Dupuis et al., 2005; Tachiiri et al., 2006). The single-
stranded, positive-sense WNV genomic RNA is approximately
11 kb and encodes a single long polyprotein that is post-
translationally processed by viral and host cellular proteases
into three structural proteins and seven nonstructural proteins
(Brinton, 2002). Comparisons of sequence data for full and⁎ Corresponding author. Arbovirus Laboratories, 5668 State Farm Road,
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doi:10.1016/j.virol.2007.06.008partial genomes of WNV over the course of the virus' spread
throughout the U.S. demonstrate that there has been minimal
genetic change since its introduction in 1999 (Davis et al.,
2004). Although WNV has remained relatively genetically
homogeneous in the U.S., a new WNV genotype emerged late
in the 2001 transmission season and has gradually established
itself as the dominant genotype of WNV in the U.S. (Davis et
al., 2005; Ebel et al., 2004). Concurrent with the emergence of
this new genotype was the rapid spread of WNVacross the U.S.
leading to the largest recorded epidemic of arboviral encepha-
litis in the western hemisphere (CDC 2002). Several studies
have confirmed the presence of distinct WNV genetic variants
existing at temporal and geographical foci (Beasley et al., 2003;
Davis et al., 2004, 2005); for example, small plaque isolates of
WNV that exhibited attenuated properties in vitro and in vivo
were collected in Texas in 2003 (Davis et al., 2004).
Small-plaque variants of other flaviviruses have been
isolated in the laboratory. An isolate of dengue virus type 2
exhibited a mixed plaque phenotype in LLC-MK cells, and a
small plaque subline selected from the mixed population in
primary green monkey kidney cells was temperature sensitive
Fig. 1. Plaque morphology of wild-type (WT) and a small plaque (SP) variant
WNV. Vero cells in 6-well plates were infected with Vero cell amplified WT or
SP stock virus, and plaques were visualized 3 days post-infection after staining
with neutral red. (A) Plaques were examined with a Zeiss Stemi 2000-C stereo
microscope, and images were captured with a Zeiss Axiocam MRC digital
camera. (B) Plaque sizes were measured using AxioVision 3.0 software (Zeiss,
Germany). For each virus, 200 individual plaques were measured and analyzed
by Graph Pad Prism (v.4.0). Bar within the box represents the median value,
boxes extend from 25th to 75th percentile, and error bars represent highest and
lowest values. Statistical analysis by t-test, Pb0.0001.
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al., 1976). A small plaque antigenic variant of Japanese
encephalitis virus (JEV) was selected in Vero cell culture in
the presence of a neutralizing monoclonal antibody, E3.3; this
variant exhibited resistance to MAb3.3, but showed neuroviru-
lence and neuroinvasiveness similar to the parental strain (Wu et
al., 1997). Chemically mutated JEV, tick-borne encephalitis
virus (TBEV), and dengue virus type 4 (DENV-4) have all
manifested small plaque phenotypes, ts, and attenuated patho-
genicity in mice (Blaney et al., 2001, 2002, 2003; Eastman and
Blair, 1985; Hanley et al., 2002; Rumyantsev et al., 2006).
Neuroblastoma cell-adapted yellow fever 17D virus exhibited a
small plaque morphology, as well as defective cell penetration,
poor cell-to-cell spread, and reduced growth efficiency,
attributed to amino acid substitutions at positions 360 and 362
in the envelope protein (Chambers and Nickells, 2001; Nickells
and Chambers, 2003; Vlaycheva and Chambers, 2002;
Vlaycheva et al., 2004, 2005). An Ala to Pro single amino
acid substitution in NS2A30 of WNVKUN strain resulted in
abortive viral replication with low titer, absence of detectableFig. 2. Comparison of growth of wild-type (WT) and a small plaque (SP) variant WN
infected with Vero cell amplified WTor SP stock virus in triplicate at an MOI of 0.01
at the indicated temperatures. Virus was harvested from the medium at various time
Symbols represent the mean titer and standard deviation for each time point. The li
cultures; in cases where the sample had no detectable virus, a titer of 0.65 log10pfu/plaques, and high level INFα/β production in A549 (human
alveolar basal epithelial) cells; however, in BHK cells, the
strain's plaque size and replication efficiency were comparable
to those of the wild-type (Liu et al., 2006).
Here we report a small-plaque (SP) variant selected from the
mutant spectrum of WNV isolated from an American crow
collected in New York in 2000. This variant was characterized
in vitro in mammalian, avian, and mosquito cell lines, and in
vivo in Culex pipiens (L.) mosquitoes. We demonstrate that this
SP variant is attenuated both in vitro and in vivo.
Results
Isolation and characterization of the small-plaque variant
The plaque morphology of the SP variant of WNV, isolated
as described in Materials and methods, was compared to the
parental wild-type strain (WT). In Vero cells, at 72 h post
infection (hpi), WT exhibited a mixed-plaque phenotype,
producing both large and small plaques while the SP virus
had uniformly small plaques (Fig. 1A). At this time point, SP
virus plaques (mean: 0.44 mm in diameter, range: 0.20–
0.83 mm) were significantly smaller than those of WT (mean:
1.62 mm, range: 0.34–2.87 mm; Pb0.001, t-test; Fig. 1B). In
this analysis, 100% of the SP population exhibited plaques less
than 1.0 mm in diameter, whereas 91.5% of the WT plaques
were larger than 1.0 mm.
In vitro growth kinetics
Growth of WT virus and the SP variant were compared in
mammalian (Vero), avian (DF-1 and PDE), and mosquito (C6/
36) cell lines. In Vero and DF-1 cells, at temperatures at or
below 37 °C, the SP variant grew to significantly lower titers
than did the WT (Pb0.01, t-test; Fig. 2), but in PDE cells at
37 °C and 39 °C, the titers of WT and SP were similar. At
higher temperatures, the growth kinetics of SP were dependent
on the cell type. In avian cells, SP growth was severely
restricted at temperatures at or above 41 °C, suggesting that the
virus is ts in these cells. In Vero cells, although SP replicated
more slowly than WT at 41 °C and 42.5 °C, the WT titers were
equal to or lower than SP titers at later time points. This pattern
could be due to high levels of WT viral replication resulting in
increased cell mortality or deterioration of viable virus at high
temperatures.
The small-plaque phenotype was retained following growth
of the SP variant in all cell types at 30 °C, 34 °C, and 37 °C.
However, in Vero and DF-1 cells at or above 41 °C, reversion to
a mixed plaque phenotype was observed, with the proportion of
plaques larger than 1.0 mm in diameter increasing with
increasing temperature (data not shown). In PDE cells, growthV in three vertebrate cell lines. Vero, DF-1, and PDE cells in 6-well plates were
pfu/cell, based on Vero cell titers. Both infection and incubation were carried out
points after infection, and titers were determined by plaque assay on Vero cells.
mit of detection (LOD) was 0.7 log10pfu/0.1 ml of supernatant of infected cell
0.1 ml was used for calculations.
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mixed plaque phenotype, and at 42.5 °C no virus was recovered,
indicating that SP failed to grow at this latter temperature.
In contrast to the results with mammalian and avian cells, SP
exhibited replication efficiency similar to that of WT in C6/36
cells, with nearly equal virus titers at all incubation temperatures
(Fig. 3A). While peak virus titers of both viruses were reached
by 96 h at 30 °C and 34 °C, neither virus reached its peak titer in
this cell line by 120 h at 26 °C, indicating that the replication of
both virus strains was enhanced by increased incubation
temperature. There was no reversion to a mixed plaque pheno-
type following growth of the SP variant in mosquito cells.
In vivo growth kinetics in C. pipiens
The ID50 values of WT and SP WNV following intrathoracic
(IT) inoculation of C. pipiens were not significantly different:
0.5 pfu/mosquito and 2.1 pfu/mosquito, respectively. Growth
analyses were performed by inoculation of mosquitoes with 10
times the ID50 of each virus to ensure that all mosquitoes
became infected. SP grew more slowly than WT in mosquitoes
at 15 °C, 27 °C, and 32 °C (Fig. 3B), in contrast to the in vitro
results in the mosquito cell line. The mean virus titer of SP at
27 °C was significantly lower than that of WT at all time pointsFig. 3. Comparison of growth of wild-type (WT) and a small plaque (SP) variant WN
6-well plates were infected with Vero cell amplified WT or SP stock virus in tripl
indicated time points and titers determined by plaque assay on Vero cells. Symbols
detection (LOD) was 0.7 log10 pfu/0.1 ml of supernatant of infected cell cultures; in
was used for calculations. (B) C. pipiens mosquitoes were inoculated intrathoracicall
Vero cell amplified WT or SP stock virus, and were maintained at the indicated te
inoculation, and 10 mosquitoes were harvested at each time point thereafter. Viral
Symbols represent the mean viral titer and standard deviation for each time point. T
sample had no detectable virus, a titer of 0.65 log10pfu/mosquito was used for calcfrom 2 to 28 days post-inoculation (dpi) (Pb0.01, t-test). Peak
titers, 6.0 and 7.4 log10pfu/mosquito for SP and WT,
respectively, were reached after 14 dpi. At 32 °C, rates of
replication of both SP and WT were accelerated compared to
those at 27 °C, and peak titers, which were similar to those
found at 27 °C, were reached earlier, by 6 dpi. At 15 °C, WTand
SP viruses replicated more slowly than at the higher tempera-
tures (Fig. 3B). WT replication, undetectable until 7 dpi,
reached a mean titer of 6.3 log10pfu/mosquito on day 84 pi;
this titer was still lower than the peak titers at 27 °C and 32 °C
(7.4 log10pfu/mosquito). Virus was not detected in the majority
of SP-infected mosquitoes until 21 dpi; the maximum titer of
2.8 log10pfu/mosquito at 84 dpi was significantly lower than
both the WT titer at 15 °C and the SP titers at 27 °C and at
32 °C.
SP began to exhibit a mixed plaque phenotype in some
individual mosquitoes after 2, 5, and 28 dpi at 32 °C, 27 °C, and
15 °C, respectively, but the proportion of mosquitoes in which
the phenotype reverted to WT, did not vary significantly among
the temperatures examined (Table 1). At each time point,
mosquitoes infected with SP that exhibited mixed plaque
phenotype usually had higher virus titers than mosquitoes
whose SP infection retained the small-plaque phenotype (data
not shown).V in vitro in a mosquito cell line and in vivo in mosquitoes. (A) C6/36 cells in
icate at an MOI of 0.01 pfu/cell. Virus was harvested from the medium at the
represent the mean titer and standard deviation for each time point. The limit of
cases where the sample had no detectable virus, a titer of 0.65 log10 pfu/0.1 ml
y at 10× the ID50 of WT (5 pfu per mosquito) or SP (21 pfu per mosquito) with
mperatures. Five mosquitoes per virus were harvested immediately following
titers in the mosquito bodies were determine by plaque titration on Vero cells.
he limit of detection (LOD) was 0.7 log10 pfu/mosquito, and in cases where the
ulations.
Fig. 4. Virus titers of wild-type (WT) and small plaque (SP) variant WNV in
C. pipiens bodies at 7 and 14 days after oral infection with the C6/36 cell
amplified virus. Mosquitoes were fed on defibrinated goose blood containing
108.4 pfu/ml of eitherWTor SP virus, incubated at 27 °C, and harvested at 7 or 14
days post-feeding (PF). Virus recovered from eachmosquito bodywas tittered on
Vero cells; each symbol represents the titer from an individual mosquito. The
mean titer of SP was significantly less thanWTat both 7 and 14 days PF by t-test
(P7=0.001; P14=0.001). For both SP and WT the mean titer at 7 day PF was
significantly lower than at 14 day PF by t-test (PSP=0.012; PWT=0.001).
Table 1
Phenotypic reversion of SP variant of WNV recovered from infected Culex
pipiens a
Incubation
temperature
(°C)
No. virus-positive
mosquitoes b
No. mosquitoes with virus that
displayed a mixed-plaque phenotype c
(% of virus-positive mosquitoes)
15 62 9 (14.5%)
27 105 14 (13.3%)
32 92 18 (19.5%)
a Mosquitoes were inoculated intrathoracically with Vero cell amplified SP
virus at 21 pfu per mosquito, and maintained at the indicated temperatures.
b Number of SP-infected mosquitoes with detectable virus, evaluated by
plaque assay on Vero cells (includes mosquitoes harvested at various times post
inoculation).
c SP virus recovered frommosquitoes had a mixed-plaque phenotype when 10
to 70% of its plaques were greater than 1.0 mm in diameter, measured at 72 hpi
on Vero cells.
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The vector competence of SP in C. pipiens was compared to
that of WT. At both day 7 and day 14 following peroral
infection, the percentage of mosquitoes infected by feeding on
SP was significantly lower than for WT (Pb0.01), and there
was no significant increase in the rate of infection from day 7 to
day 14 post-feeding (PF) (Table 2). Dissemination and trans-
mission rates of SP-infected mosquitoes were similar to the
rates for WT at day 7, but they were significantly lower than the
rates for WT at day 14, resulting in a greater proportion of WT-
infected mosquitoes with disseminated virus (71% vs. 12%;
Pb0.01) and transmitting virus (51% vs. 9%; Pb0.01) than
those infected with SP. The higher infection, dissemination, and
transmission rates for WT were reflected in the titers of virus
recovered from bodies of infected mosquitoes (Fig. 4). Mean
body titers were significantly greater for WT than for SP at both
7 and 14 days PF (Pb0.01), and mean titers for both WT- and
SP-infected mosquitoes increased significantly from day 7 to
day 14. Mosquitoes with disseminated infections generally hadTable 2
Vector competence of SP and WT strains of WNV in Culex pipiens
Virus Day
PF a
No.
fed b
No. infected
(%) c
No. disseminated
(%) d
No. transmitting
(%) e
SP 7 50 21 (42) f 3 (14) f 1 (5) f
14 65 34 (52) f 7 (21) f 3 (9) f
WT 7 50 36 (72) g 6 (17) f 1 (3) f
14 41 35 (85) g 25 (71) g 18 (51) g
a Day post-feeding with the C6/36 cell amplified WTor SP virus, oral dose of
108.4 pfu/ml in blood meal.
b Number of fully engorged mosquitoes.
c Number of mosquitoes with detectable virus in their bodies (expressed as
percentage of those fed).
d Number of mosquitoes with detectable virus in their legs (expressed as
percentage of those infected).
e Number of mosquitoes secreting virus in saliva (expressed as percentage of
those infected).
f Within each column, any two values followed by the same letter are not
significantly different from each other (Pb0.01).
g Within each column, any two values followed by the same letter are not
significantly different from each other (Pb0.01).higher body titers, although there were exceptions among both
SP- and WT-infected individuals.
Comparison of WT and SP sequences
The complete genome of the SP variant was sequenced and
compared to the consensus sequence of the parental WT in order
to identify mutations that could be responsible for the observed
phenotypic differences. Four nucleotide differences between SP
and WT were detected. Two (C1599U and C9660U) of these
nucleotide changes were translationally silent, while two
(C625U and U3707C) resulted in amino acid changes: a proline
to serine change at position 54 (P54S) in the pr region of prM
and a valine to alanine change at position 61 (V61A) in the
NS2A protein (Table 3).
We also analyzed the prM and NS2A sequences of 70
individual plaques of mosquito- and cell culture-derived SP
viruses that exhibited phenotypic reversion. From the mosquito-
derived viruses, we picked 30 large plaques and 30 small
plaques; however, from the cell culture-derived viruses, onlyTable 3
Nucleotide and amino acid sequence changes for WNV SP variant, relative to
the parental WT sequence
Nucleotide
position
Gene/
region
Nucleotide AA change
WT a SP b
625 Pr-54 C U Proline→Serine
1599 E211 C U
3707 NS2A-61 U C Valine→Alanine
9660 NS5 C U
a WT: WNV 3356K isolated from the kidney of an American crow collected
in New York in 2000, and amplified twice in Vero cells (GenBank Accession
No. EF657887).
b SP: A small plaque variant (SP), isolated from the first Vero amplified WT
stock, followed by 2 sequential rounds of plaque purification and two rounds of
amplification in Vero cells (GenBank Accession No. EF530047).
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available for analysis after incubation at 42.5 °C. All large
plaques from mosquitoes held at 27 °C and 32 °C, as well as the
large plaques from the cell culture-derived viruses, had reverted
from the SP sequence to the WT sequence at prM 625 (Table 4);
however, half of the small plaques from these mosquitoes also
contained the WT sequence at prM 625. Both large and small
plaques from one mosquito held at 15 °C had reverted to theWT
sequence at prM 625. Three large and two small plaques from a
second mosquito held at 15 °C had reverted to the WT sequence
at NS2A 3707 (Table 4), while one large plaque had reverted at
both positions. Four plaques from this mosquito, including one
large plaque, contained the SP sequence at both prM 625 and
NS2A 3707.
Discussion
Flaviviruses frequently demonstrate mixed-plaque morpho-
logy in cell culture (Butrapet et al., 2000; Davis et al., 2004).
Experimentally mutagenized flaviviruses have been found to
yield small plaque variants that are ts in cell culture (Eckels et
al., 1976) and attenuated in mice (Blaney et al., 2001, 2002,
2003; Hanley et al., 2002; Liu et al., 2006). In this study, SP, a
small-plaque viral variant, was selected from the mixed-plaque
population of WNV isolated from an American crow collected
in NY in 2000. Its replication efficiency in Vero cells was
significantly lower than that of WT, and this difference was
retained across a wide temperature range. In avian cell lines, SP
growth was equal to or slower than WT growth at low
temperatures, but at temperatures above 39 °C, SP exhibited
temperature sensitivity. Both viruses grew equally well in the
mosquito cell line, C6/36. Thus, it was surprising to observe that
both IT and peroral infection of C. pipiens mosquitoes resulted
in significantly lower virus titers and infection rates for SP than
for WT. Interestingly, although other small-plaque WNV strains
have demonstrated a ts phenotype in Vero cell culture (Davis etTable 4
Sequence analysis of revertant viruses derived from SP-infected mosquitoes or
cells
Source of
virus
Incubation
temperature
(°C)
Plaques
picked
prM 625
(U to C)
reversion
NS2A 3707
(C to U)
reversion
2 mosquitoes 15 10 lp a 6 b 4 b
10 sp c 5 2
2 mosquitoes 27 10 lp 10 0
10 sp 4 0
2 mosquitoes 32 10 lp 10 0
10 sp 5 0
Vero 42.5 5 lp 5 0
DF-1 42.5 5 lp 5 0
Ten-fold serial dilutions of virus recovered from SP infected mosquitoes and
Vero or DF-1 cells were plated on Vero cell monolayers in 6-well plates. Well-
isolated plaques were picked from the wells containing only 1 or 2 plaques at
72 hpi.
a lp: plaque diameter equal to or larger than 1 mm.
b Includes one large plaque with double reversion.
c sp: plaque diameter smaller than 1 mm.al., 2004; Wicker et al., 2006), the SP variant characterized here
did not.
WNV is maintained in a transmission cycle primarily bet-
ween ornithophilic mosquitoes and passeriform birds. World-
wide, Culex spp. are considered to be the primary vectors for
WNV transmission; members of the C. pipiens complex are the
principal vectors of WNV in northeastern and north central US.
The SP variant described here was attenuated in C. pipiens
following both parenteral and peroral infection, and it exhibited
lower dissemination and transmission rates at 14 days following
feeding as compared to WT. These results suggest that SP has a
defect that blocks cell-to-cell spread. Future studies are planned
using the SP variant as a tool to help elucidate the determinants
of WNV spread in vivo.
The observation that WNV exists as a genetically diverse
population in its natural mosquito and avian hosts (Jerzak et al.,
2005) is most likely a consequence of the high mutation rate
resulting from the error-prone RNA-dependent RNA polymer-
ase (Domingo et al., 2005). In studies of other flaviviruses where
mutations were chemically induced, the small-plaque pheno-
types did not appear to be stable with in vitro passaging, but
rather demonstrated high rates of reversion. More than 2/3 of ts
and/or small-plaque mutants of DENV-4 lost these phenotypes
after two rounds of biological cloning (Blaney et al., 2002);
similarly, N80% of JEV clones lost the ts phenotype during three
rounds of plaque purification (Eastman and Blair, 1985). The
WNV SP variant described here was stable through three rounds
of plaque purification and two amplification rounds that were
carried out before the current experiments were performed.
During subsequent growth assays, the small-plaque phenotype
was retained in all cell lines except Vero and DF-1 grown at
temperatures at or above 41 °C. The correlation of the change to
a mixed plaque size phenotype with in vitro growth under the
stressful condition of high temperature suggests a selective
advantage for the larger-plaque phenotype. It was interesting that
larger plaques were not generated when SP was grown in PDE
cells at 41 °C; the lack of change in plaque phenotyope may
explain why no virus growth was detected in this cell culture
when the temperature was raised to 42.5 °C. It is not clear why
SP reverted to a mixed-plaque phenotype in DF-1 but not in
PDE, since both cell lines are of avian origin. In contrast to the in
vitro results, phenotypic reversion to WT plaque sizes was
observed at all incubation temperatures, from 15 °C to 32 °C,
after infection of live mosquitoes with SP. SP virus that exhibited
a mixed plaque phenotype after recovery from mosquitoes often
had titers similar to those of WT, although phenotypic reversion
of SP in vitro did not appear to restore replication efficiency to
WT levels.
Small plaque variants commonly are found in natural
populations. We have isolated seven additional small plaque
variants from other WNV isolates collected in NY from 2000 to
2004, each having mutations different from those detected in the
particular SP variant characterized in this study (data not shown).
Using site-directed mutagenesis, Davis et al. demonstrated that a
mutation in the NS4B protein (E249G) in combination with either
amutation in theNS5 protein (A804V) or threemutations in the 3′
UTR (A10596G, C10774U, A10799G) was sufficient to produce
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viruses isolated in Texas in 2003 (Davis et al., 2004, 2007). Other
work has shown that WNV containing only the E249G mutation
in NS4B exhibited smaller plaques, slower growth kinetics, and
decreased RNA synthesis as compared to the wild-type virus
(Puig-Basagoiti et al., 2007). These data illustrate that different
mutations in the WNV genome can produce virus variants with
small plaque phenotypes.
The SP sequence contained four nucleotide changes from the
sequence of WT. Two of these changes resulted in amino acid
substitutions, a P54S change in the prM protein, and a V61A
change in the NS2A protein. The prM protein plays a crucial role
in virus assembly and transportation and exhibits a chaperone-
like activity critical for proper folding and maturation of the viral
E protein (Brinton, 2002). A deletion at the cleavage site of prM
of TBEV did not influence virus replication and release from
infected BHK cells, but the progeny virus lost the ability to infect
new BHK cells; infectivity was restored by the addition of
trypsin (Elshuber et al., 2003). A different mutation in prM of
TBEV reduced particle secretion, but did not affect envelope
protein folding or the chaperone-like activity of prM (Yoshii et
al., 2004). NS2A is a small hydrophobic protein that plays an
important role in virus replication (Brinton, 2002) and is a major
inhibitor of interferon promoter-driven transcription (Liu et al.,
2005). A single amino acid substitution in the NS2A (A30P)
region of a Kunjin isolate (WNVKUN) resulted in attenuation of
both neurovirulence and neuroinvasiveness (Liu et al., 2006).
Sequencing of the SP mixed plaque population revealed that
35 out of 40 large plaques from mosquitoes and cells had
reverted to the WT sequence at prM 625, three reverted to the
WT sequence at NS2A 3707, and one reverted at both positions
(Table 4). These data suggest that the prM mutation in SP may
contribute to its small plaque phenotype, although the NS2A
mutation may also be involved. However, 14 out of 30 small
plaques also reverted at prM 625 and two reverted at NS2A
3707, indicating that genotypic reversion at either of these
positions is not sufficient to restore the WT plaque size
phenotype. In addition, as the entire genomes of the plaque-
purified viruses were not sequenced, we cannot evaluate the
potential contributions of any other sequence changes that may
be present. Studies are currently underway to determine the
relative contributions of the prM and NS2A amino acid changes
to the SP phenotypes observed here; this information should
enable the potential mechanism of attenuation of the SP variant
to be clarified.Materials and methods
Viruses and cells
African green monkey kidney cells (Vero, ATCC #CCL-81)
were grown in minimal essential medium (MEM; Gibco,
Invitrogen Corp., Carlsbad CA) supplemented with 10% fetal
bovine serum (FBS; Hyclone, Logan, UT), 2 mM L-glutamine,
1.5 g/l sodiumbicarbonate, 100U/ml of penicillin, and100μg/ml
of streptomycin. Aedes albopictus cells (C6/36; ATCC #CRL-1660) were grown inMEM supplemented with 10% FBS, 2 mM
L-glutamine, 1.5 g/l sodium bicarbonate, 0.1 mM non-essential
amino acids, 100 U/ml of penicillin, and 100 μg/ml of
streptomycin. Chicken embryo fibroblasts (DF-1; ATCC
#CRL-12203) were grown in Dulbecco's Modified Eagle's
medium (DMEM; ATCC, Manassas, VA) with 10% FBS,
4 mM L-glutamine, 4.5 g/l glucose, 1.5 g/l sodium bicarbonate,
100 U/ml of penicillin, and 100 μg/ml of streptomycin. Peking
duck embryo fibroblasts (PDE; ATCC #CCL-141) were grown
in MEM supplemented with 10% FBS, 2 mM L-glutamine,
1.5 g/l sodium bicarbonate, 0.1 mM non-essential amino acids,
1.0 mM sodium pyruvate, 100 U/ml of penicillin, and 100 μg/ml
of streptomycin.
The WTWNV strain 3356K was isolated in Vero cell culture
from the kidney of an American crow (Corvus brachyrhynchos)
collected in New York in 2000 and passed twice in Vero cells to
amplify the virus. The SP variant was selected from the first
Vero cell passage, and then subjected to two sequential rounds
of plaque purification (total of three plaque-to-plaque transfers),
followed by two rounds of amplification in Vero cells. The cell
culture supernatants from the second round Vero cell amplifica-
tion of WT and SP were clarified by centrifugation at 3220×g
for 10 min, supplemented with 20% FBS, and aliquots were
stored at −80 °C as virus stocks. All in vitro experiments and in
vivo mosquito inoculation studies were performed using the
second round Vero-amplified virus stocks. For the mosquito
vector competence studies, second round Vero-amplified virus
stocks of WT and SP were amplified once in C6/36 cells at a
multiplicity of infection (MOI) of 0.01 plaque forming units
(pfu)/cell, based on Vero cell titer, and were harvested at 96 h
post-infection, as described above.
Mosquitoes
C. pipiens were originally collected as egg rafts in
Pennsylvania in 2004 by M Hutchinson (Pennsylvania Depart-
ment of Environmental Protection) and were colonized at the
Arbovirus Laboratories, Wadsworth Center. Mosquitoes were
maintained as previously described (Ebel et al., 2005) in
12″×12″×12″ cages at 27 °C with 16:8 h light:dark photo-
period and provided 10% sucrose ad lib.
Measurement of plaque size
WTand SP viral stocks were inoculated onto Vero cells in 6-
well culture plates as described previously (Payne et al., 2006).
After staining with neutral red, plaques were examined at 72 h
post-infection using a Zeiss Stemi 2000-C stereo microscope,
and images were captured with a Zeiss Axiocam MRC digital
camera. Plaque sizes were measured using AxioVision 3.0
software (Zeiss, Germany). For analysis, 200 individual plaques
were measured for each virus.
In vitro growth kinetics
Vero, C6/36, DF-1, and PDE cells were seeded in Costar 6-
well culture cluster plates (Corning Incorporated, Corning,NY) at
346 Y. Jia et al. / Virology 367 (2007) 339–34737 °C, 28 °C, 39 °C, and 37 °C, respectively, in 5% CO2.
Confluent cell monolayers were inoculated with virus at an MOI
of 0.01, based on Vero cell titer. After 1 h of viral adsorption, the
inoculum was removed and the monolayers were washed and
overlayed with 3 ml of the appropriate maintenance medium
containing 2%FBS. Vertebrate cells were incubated at each of the
following temperatures: 30 °C, 34 °C, 37 °C, 40 °C (39 °C for DF-
1 and PDE), 41 °C, and 42.5 °C (Vero, DF-1, PDE). Mosquito
cells were incubated at 26 °C, 28 °C, 30 °C, and 34 °C. The
temperatures for virus adsorption were the same as the incubation
temperature used subsequently in all growth curve experiments.
Samples were harvested at 12 (for PDE), 24, 36, 48, 72, 96, and
120 h post-infection into media containing 20% FBS and were
stored at −80 °C. All growth curves were performed using
triplicatewells. Plaque assayswere conducted as described above.
Viral titers were calculated and expressed as log10pfu/0.1 ml.
Determination of mosquito ID50
Four groups (n=20 each) of 6-day old C. pipiensmosquitoes
were inoculated IT essentially as previously described (Rosen
and Gubler, 1974) with approximately 10, 1, 0.1, or 0.01 pfu of
either SP or WT. Inoculated mosquitoes were maintained at
27 °C, with a 16:8 light:dark photoperiod, and were provided
with a 10% sucrose solution ad lib on cotton wicks. On day 7
post-inoculation, mosquitoes were individually frozen in 1.0 ml
of mosquito diluent (MD: PBS with 20% FBS, 100units/ml
penicillin, 100 μg/ml streptomycin, 0.25 μg/ml fungizone, and
10 μg/ml gentamicin) for subsequent trituration and screening
on Vero cell culture to determine infection rates at each dose.
In vivo growth kinetics in C. pipiens
Six-day old C. pipiens mosquitoes were inoculated IT with
WT or SP at 10 times the ID50 and maintained at 15 °C, 27 °C,
or 32 °C, as described above. Immediately following inocula-
tion, 5 mosquitoes were placed individually in 1.0 ml mosquito
diluent and stored at −80 °C for subsequent trituration and
titration on Vero cells. At each subsequent timepoint, 10
mosquitoes per virus strain were harvested, as described above.
Vector competence of C. pipiens
Four- to six-day old female C. pipiens mosquitoes were
deprived of sucrose solution for approximately 44 h and then
allowed to feed for 1 h on gauze pledgets soaked with
defibrinated goose blood containing 108.4 pfu/ml of either WT
or SP virus supplemented with 2.5% sucrose. Fully engorged
mosquitoes were removed to pint cartons, incubated at 27 °C
under a 16:8 light:dark photoperiod, and provided a 10%
sucrose solution ad lib on cotton wicks.
After 7 and 14 days post feeding (PF), mosquito salivary
secretions were collected in capillary tubes charged with 50%
sucrose plus fetal bovine serum (1:1), as previously described
(Ebel et al., 2005) to estimate transmission rates. Bodies and legs
were placed in separate microfuge tubes with 1.0 ml mosquito
diluent, homogenized using a rapid high speed mechanicalhomogenizer (Mixer Mill MM300; Qiagen, Valencia, CA) for
30 s at 24 cycles/s, and clarified by centrifugation (4 min at
5796×g). Bodies, legs, and salivary secretions were screened or
titrated in Vero cell culture to determine infection, dissemina-
tion, and transmission rates, respectively.
Genome sequencing and analysis
Nucleotide sequencing of the full genome of SP and WTwas
conducted as described (Davis et al., 2005). Briefly, viral RNA
was extracted directly from 100 μl of the second round Vero-
amplified virus stocks using the QiaAMP viral RNA extraction
kit (Qiagen, Valencia, CA). The genomic RNA was reverse
transcribed and amplified in 16 overlapping fragments using
one-step RT-PCR (Qiagen, Valencia, CA). RT-PCR products
were electrophoretically separated on a 1.5% agarose gel, and
bands of the appropriate size were excised and gel purified
using the QiaQuick Gel Extraction Kit (Qiagen, Valencia, CA),
according to the manufacturer's protocol. Full-length sequen-
cing was carried out using multiple pairs of overlapping primers
and was performed using an ABI 373 or 377 automated
sequencer according to the manufacturer protocols. A compre-
hensive description of the amplification and sequencing primers
is available from the corresponding author.
Sequences were compiled and edited using the SeqMan
module of the DNAStar software package (DNAStar, Inc.,
Madison, WI) with a minimum of two-fold redundancy
throughout for sequence data to be considered complete.
Sequences were aligned using MegAlign within DNAStar,
and changes between the SP variant and WT sequence were
documented.
Sequence analysis of revertant SP virus from mosquitoes
and cells
Virus derived from SP infected mosquitoes by IT inoculation
(twomosquitoes from each incubation temperature) or harvested
from Vero or DF-1 cells incubated at 42.5 °C with reverted
plaque phenotype, were plated on Vero cells. Ten plaques (five
large and five small plaques) were picked from each mosquito-
derived virus, and five large plaques were picked from cell
culture-derived viruses. Viral RNA extraction, RT-PCR, sequen-
cing, and sequence analysis were conducted as described above.
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